Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Sort by:
Need a comprehensive medical report on "Triptorelin Pamoate for Injectable Suspension"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
Phase 2
Active, not recruiting
- Conditions
- Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
- Interventions
- First Posted Date
- 2021-05-03
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Hongqian Guo
- Target Recruit Count
- 75
- Registration Number
- NCT04869371
- Locations
- 🇨🇳
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath